Naloxazone: Difference between revisions
Jump to navigation
Jump to search
m (Robot: Automated text replacement (-{{SIB}} +, -{{EH}} +, -{{EJ}} +, -{{Editor Help}} +, -{{Editor Join}} +)) |
m (Robot: Automated text replacement (-{{WikiDoc Cardiology Network Infobox}} +, -<references /> +{{reflist|2}}, -{{reflist}} +{{reflist|2}})) |
||
| Line 28: | Line 28: | ||
==References== | ==References== | ||
{{reflist}} | {{reflist|2}} | ||
{{opioids}} | {{opioids}} | ||
Latest revision as of 20:01, 4 September 2012
Template:Chembox new Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
Overview
Naloxazone is an irreversible μ opioid receptor antagonist which is selective for the μ1 receptor subtype.[1]
References
- ↑ Pasternak GW, Childers SR, Snyder SH. "Opiate analgesia: evidence for mediation by a subpopulation of opiate receptors." Science. 1980 May 2; 208(4443):514-6. PMID 6245448. doi:10.1126/science.6245448